FSMAX
Price
$117.72
Change
-$1.39 (-1.17%)
Updated
Aug 20 closing price
Net Assets
40.08B
JANEX
Price
$154.94
Change
-$1.31 (-0.84%)
Updated
Aug 20 closing price
Net Assets
21.85B
Interact to see
Advertisement

FSMAX vs JANEX

FSMAX vs JANEX Comparison Chart in %
View a ticker or compare two or three
VS
FSMAX vs. JANEX commentary
Aug 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Hold and JANEX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 40.1B vs. JANEX (21.8B). FSMAX pays higher dividends than JANEX: FSMAX (0.50) vs JANEX (0.16). FSMAX was incepted earlier than JANEX: FSMAX (15 years) vs JANEX (34 years). JANEX (0.79) is less costly to investors than FSMAX (0.04). FSMAX is a more actively managed with annual turnover of: 23.00 vs. JANEX (17.00). FSMAX has a lower initial minimum investment than JANEX: FSMAX (0) vs JANEX (2500). FSMAX annual gain was more profitable for investors over the last year : 23.68 vs. JANEX (5.24). FSMAX return over 5 years is better than : 40.14 vs. JANEX (-10.28).
FSMAXJANEXFSMAX / JANEX
Total Expense Ratio0.040.794%
Annual Report Gross Expense Ratio0.040.794%
Fund Existence15 years34 years-
Gain YTD16.9379.545177%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets40.1B21.8B184%
Annual Yield % from dividends0.500.16322%
Returns for 1 year23.685.24452%
Returns for 3 years72.7419.46374%
Returns for 5 years40.14-10.28-391%
Returns for 10 years134.4965.47205%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CIICX51.040.58
+1.15%
American Funds Intl Gr and Inc 529-C
FCUCX20.460.08
+0.39%
NYLI PineStone U.S. Equity Class C
ISCGX5.500.02
+0.36%
Transamerica Small Cap Growth I
HFDCX20.760.06
+0.29%
Hartford Schroders US MidCap Opps C
FHCCX43.67N/A
N/A
Fidelity Advisor Health Care C